(Reuters) – Private equity firms are mulling over a $10 billion plan to buy and merge older drug brands of Britain’s GlaxoSmithKline and France’s Sanofi , the Financial Times reported on Sunday,…

from Reuters: Deals http://ift.tt/1uYe9zG
via IFTTT

Publicités